TITLE

Molecular genetics of Alport syndrome

AUTHOR(S)
Tryggvason, Karl; Jing Zhou; Hostikka, Sirkka Liisa; Shows, Thomas B.
PUB. DATE
January 1993
SOURCE
Kidney International;Jan1993, Vol. 43 Issue 1, p38
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Alport syndrome is a progressive hereditary kidney disease characterized by hematuria, sensorineural hearing loss and ocular lesions with structural defects in the glomerular basement membrane (GBM). The gene frequency has been estimated to be 1:5000. The disease is primarily X chromosome-linked. but autosomal forms have also been reported. The X-linked form has been shown to be caused by mutations in a recently identified α5(IV) collagen chain gene (COL4A5). We have isolated cDNA clones for providing the entire primary structure of the human α5(IV) chain. The gene has been located to the Xq22 region. Using antibodies against synthetic peptides, the α5(IV) chain was shown to be located in the kidney only in the glomerular basement membrane. Thus far, the exon-intron structure has been determined for a large portion of the gene which probably has a size of over 200 kb. Numerous different mutations have been identified in the COL4A5 gene. The mutations include single base mutations, large deletions and other major rearrangements such as inversion and duplication. The consequences of the mutations observed can be considered sufficient to cause structural and functional defects in the type IV collagen molecule and. therefore, also the GBM network. This, in turn can explain the disruption of the GBM and hematuria occurring in these Alport patients. Alport syndrome is the first genetic basement membrane and kidney disease whose gene has been cloned. These recent results have enabled the development of antibodies and DNA probes for accurate diagnosis of Alport syndrome.
ACCESSION #
14906260

 

Related Articles

  • Molecular genetics of basement membranes: The paradigm of Alport syndrome. ANTIGNAC, CORINNE // Kidney International Supplement;Jun1995, Issue 49, pS29 

    The article studies the molecular genetics of glomerular basement membranes (GBM) through the paradigm of Alport syndrome (AS). AS, a progressive hereditary nephritis, is associated with sensorineural hearing impairment and ocular lesions. Certain peculiar unstructural changes of GBM include...

  • A Novel Mutation in a Kazakh Family with X-Linked Alport Syndrome. Baikara, Barshagul T.; Zholdybayeva, Elena V.; Rakhimova, Saule E.; Nigmatullina, Nazym B.; Momynaliev, Kuvat T.; Ramanculov, Yerlan M. // PLoS ONE;7/13/2015, Vol. 10 Issue 7, p1 

    Alport syndrome is a genetic condition that results in hematuria, progressive renal impairment, hearing loss, and occasionally lenticonus and retinopathy. Approximately 80% of Alport syndrome cases are caused by X-linked mutations in the COL4A5 gene encoding type IV collagen. The objective of...

  • Membranous nephropathy with anti-tubular basement membrane antibody may be X-linked. Tay, Agnes H. N.; Ren, Ee-Chee; Murugasu, Belinda; Sim, Sze-Keen; Tan, Puay-Hoon; Cohen, Arthur H.; Yap, Hui-Kim // Pediatric Nephrology;Aug2000, Vol. 14 Issue 8/9, p747 

    The association of membranous nephropathy with Fanconi syndrome and anti-tubular basement antibodies appears to be a distinct subset of familial membranous nephropathy. We studied two Chinese families with four affected boys to evaluate the mode of inheritance of disease. HLA haplotype analysis...

  • Identification of variant Alport phenotypes using an Alport-specific antibody probe. Kashtan, Clifford E.; Atkin, Curtis L.; Gregory, Martin C.; Michael, Alfred F. // Kidney International;Oct1989, Vol. 36 Issue 4, p669 

    An antibody, which recognizes an epitope(s) on a 26 kD peptide of the noncollagenous domain of type IV collagen and which fails to bind to basement membranes of individuals with Alport syndrome, was used to characterize members of families representing phenotypic variants of the disorder. Ten of...

  • Novel heterozygous COL4A3 mutation in a family with late-onset ESRD. Hoefele, Julia; Lange-Sperandio, Bärbel; Ruessmann, Despina; Glöckner-Pagel, Judith; Alberer, Martin; Benz, Marcus; Nagel, Mato; Weber, Lutz // Pediatric Nephrology;Aug2010, Vol. 25 Issue 8, p1539 

    Thin basement membrane nephropathy (TBMN) and Alport syndrome (ATS) are genetically heterogeneous conditions characterized by structural abnormalities in the glomerular basement membrane (GBM). TBMN presents with hematuria, minimal proteinuria, and normal renal function. Although TBMN is an...

  • Dysmorphic hematuria demonstrates disease or carrier status in Alport's syndrome.  // Kidney;Sep/Oct2002, Vol. 11 Issue 5, p197 

    Presents a summary of the study 'A Comparison of the Clinical, Histopathologic, and Ultrastructural Phenotypes in Carriers of X-Linked and Autosomal Recessive Alport's Syndrome,' by H. Dagher, M. Buzza, D. Colville, et al, published in a 2001 issue of the 'American Journal of Kidney Diseases.'

  • Molecular genetics of hereditary nephritis.  // Kidney International;Sep1992, Vol. 43 Issue 3, p783 

    The article presents two clinical cases of hereditary nephritis. They include the case of a 19-year old male who was referred for evaluation of a glomerulopathy, where his annual evaluation has revealed persistent microscopic hematuria and 24-hour protein excretion. The case of a 19-year old...

  • GENETIC DISORDERS - DEVELOPMENT Autosomal-dominant Alport syndrome: Natural history of a disease due to COL4A3 or COL4A4 gene. Pescucci, Chiara; Mari, Francesca; Longo, Ilaria; Vogiatzi, Paraskevi; Caselli, Rossella; Scala, Elisa; Abaterusso, Cataldo; Gusmano, Rosanna; Seri, Marco; Miglietti, Nunzia; Bresin, Elena; Renieri, Alessandra // Kidney International;May2004, Vol. 65 Issue 5, p1598 

    Autosomal-dominant Alport syndrome: Natural history of a disease due to COL4A3 or COL4A4 gene. Background. Alport syndrome is a clinically and genetically heterogeneous nephropathy. The majority of cases are transmitted as an X-linked semidominant condition due to COL4A5 mutations. In this form...

  • Detection of mutations in theCOL4A5gene by analyzing cDNA of skin fibroblasts. Fang Wang; Yunfeng Wang; Jie Ding; Jiyun Yang // Kidney International;Apr2005, Vol. 67 Issue 4, p1268 

    Detection of mutations in theCOL4A5gene by analyzing cDNA of skin fibroblasts.Background.Alport syndrome is a progressive hereditary glomerulonephritis that is characterized by hematuria, sensorineural deafness, ocular lesions, and progressive renal failure. The majority of cases (about 85%) are...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics